KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microchip Technology (MCHP) Cash & Equivalents (2016 - 2025)

Microchip Technology's Cash & Equivalents history spans 17 years, with the latest figure at $250.7 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 57.22% to $250.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $250.7 million, a 57.22% decrease, with the full-year FY2025 number at $771.7 million, up 141.38% from a year prior.
  • Cash & Equivalents hit $250.7 million in Q4 2025 for Microchip Technology, up from $236.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for MCHP hit a ceiling of $771.7 million in Q1 2025 and a floor of $234.0 million in Q1 2023.
  • Historically, Cash & Equivalents has averaged $339.4 million across 5 years, with a median of $287.5 million in 2022.
  • The widest YoY moves for Cash & Equivalents: up 141.38% in 2025, down 57.22% in 2025.
  • Tracing MCHP's Cash & Equivalents over 5 years: stood at $313.5 million in 2021, then dropped by 7.85% to $288.9 million in 2022, then decreased by 2.73% to $281.0 million in 2023, then soared by 108.54% to $586.0 million in 2024, then plummeted by 57.22% to $250.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for MCHP at $250.7 million in Q4 2025, $236.8 million in Q3 2025, and $566.5 million in Q2 2025.